Clinical Trial Update: Clinical Trial Of The Effectiveness Of The Product Cloratadd D (Loratadine + Pseudoephedrine Sulfate) Produced By The Laboratory EMS S/A, Compared To The Drug Claritin D Produced By Schering-Plough S/A, In Patients With Allergic Rhinitis [Phase 3]

View source ↗

Summary

A Phase 3 randomized trial comparing Cloratadd D (loratadine + pseudoephedrine sulfate) to Claritin D was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Drugs mentioned

• Claritin D (loratadine + pseudoephedrine)
• Cloratadd D (loratadine + pseudoephedrine sulfate)

Snippet

Sponsor: Azidus Brasil | Conditions: Allergic Rhinitis | Phase 3 | Status: WITHDRAWN